Ursprung des Netzwerks ersten Grades von Kevin Luo

EinheitArt der EinheitIndustrie
229
Subsidiary Investment Banks/Brokers 229

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Kevin Luo

UnternehmenSektorVerknüpfte PersonenHauptposition
ABBOTT LABORATORIES Medical Specialties

Qi Shuai

Corporate Officer/Principal

DEUTSCHE BANK AG Investment Banks/Brokers

Qi Shuai

Director/Board Member

Investment Banks/Brokers

William Greene

Analyst-Equity

The Trustees of Columbia University in The City of New York College/University

Qi Shuai

Graduate Degree

Regional Banks

Wan Yan Mak

Director/Board Member

Investment Banks/Brokers

Eddy Wang

Daisy Dai

Camille Xu

Albert Li

Jeffrey Mak

Qi Shuai

Corporate Officer/Principal

Market Strategist

Market Strategist

Analyst-Equity

Analyst-Equity

Corporate Officer/Principal

Investment Banks/Brokers

Sean Xiang

Analyst-Equity

Investment Banks/Brokers

Chloe Liu

Analyst-Equity

University of Hong Kong College/University

Xiaofan Zhang

Eric Chiang

Undergraduate Degree

Undergraduate Degree

Investment Banks/Brokers

Chetan Ahya

Binay Singh

Economist

Analyst-Equity

Investment Banks/Brokers

Jonathan F. Garner

Viktor Hjort

Emma K. Lawson

Analyst-Equity

Market Strategist

Analyst-Fixed Income

London School of Economics & Political Science College/University

Wan Yan Mak

Undergraduate Degree

Investment Banks/Brokers

Carol Xia

Joanne Lau

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Xiaofan Zhang

Corporate Officer/Principal

Universität Rostock College/University

Daniel Wetstein

Undergraduate Degree

University of Science & Technology of China College/University

Qi Shuai

Undergraduate Degree

Investment Banks/Brokers

Joseph Lam

Chloe Liu

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Sean Wu

Samuel Lee

Sherry Yin

Analyst-Equity

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Praveen K. Choudhary

Chetan Ahya

Deyi Tan

Shawn Kim

Derrick Y. Kam

Analyst-Equity

Economist

Economist

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Sara Wang

Analyst-Equity

Investment Banks/Brokers

Ehsernta Fu

Da Yang Zhang

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Cindy Huang

Vivi Huang

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Helen Qiao

Ben Bei

Leaf Liu

Economist

Market Strategist

Analyst-Equity

Investment Banks/Brokers

Samuel Lee

Hsin Yi Tsai

Analyst-Equity

Analyst-Equity

Bain Capital Asia LLC (Shanghai) Investment Managers

Qi Shuai

Corporate Officer/Principal

HSBC Markets Asia Ltd.

Wan Yan Mak

Corporate Officer/Principal

Miscellaneous Commercial Services

Xiaofan Zhang

Chief Executive Officer

Investment Banks/Brokers

Jack Lü

Camille Xu

Lydia Lin

Analyst-Equity

Analyst-Equity

Analyst-Equity

Investment Managers

Xiaofan Zhang

Corporate Officer/Principal

The University of Chicago Booth School of Business College/University

Qi Shuai

Masters Business Admin

Investment Managers

Gokul Laroia

Chief Executive Officer

Investment Banks/Brokers

Ben Bei

Sherry Yin

Jeffrey Mak

Director of Research - Equity

Analyst-Equity

Analyst-Equity

Investment Banks/Brokers

Alexis Yan

Analyst-Equity

Regional Banks

Qi Shuai

Corporate Officer/Principal

EVEREST MEDICINES LIMITED Pharmaceuticals: Major

Xiaofan Zhang

Chief Operating Officer

CBC Group Co., Ltd.

Xiaofan Zhang

Director/Board Member

ALPHAMAB ONCOLOGY Biotechnology

Qi Shuai

Director of Finance/CFO

EverNov Medicines (Zhuhai Hengqin) Co. Ltd.

Xiaofan Zhang

Director/Board Member

Everstar Therapeutics Ltd.

Xiaofan Zhang

Director/Board Member

Everstar Medicines Shanghai Ltd.

Xiaofan Zhang

Director/Board Member

Everest Medicines (Singapore) Pte Ltd.

Xiaofan Zhang

Director/Board Member

Everid Medicines (Beijing) Ltd.

Xiaofan Zhang

Director/Board Member

Evernov Medicines Ltd.

Xiaofan Zhang

Director/Board Member

Evernov Medicine Hk Ltd.

Xiaofan Zhang

Director/Board Member

Everest Medicines Suzhou, Inc.

Xiaofan Zhang

Director/Board Member

Finance/Rental/Leasing

Wan Yan Mak

Chief Operating Officer

Financial Conglomerates

Wan Yan Mak

Chief Operating Officer

Everest Clinical Research Services, Inc. (United States)

Xiaofan Zhang

Chief Executive Officer

Investment Managers

Cathy Tang

Analyst-Equity

Statistik

International

Hong Kong 23
China 10
Vereinigte Staaten 7
Cayman Islands 5
Vereinigtes Königreich 3

Sektoral

Finance 30
Consumer Services 7
Health Technology 4
Commercial Services 2

Operativ

Analyst-Equity 126
Market Strategist 29
Director/Board Member 29
Economist 18
Corporate Officer/Principal 17
  1. Börse
  2. Insiders
  3. Kevin Luo
  4. Unternehmensverbindungen